CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)		12 Months Ended				47 Months Ended
	Dec. 31, 2024	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2025
Cash Flows from Operating Activities
Net increase in net assets resulting from operations		$ 16,939,141	$ 16,391,747	$ 15,454,039	$ 15,454,039
Adjustments to reconcile net increase in net assets from operations to net cash used in operating activities:
Purchases of investments		(135,656,548)	(119,805,183)	(89,322,601)
Proceeds from sales and repayments of investments		39,379,107	30,250,267	42,260,585
Net change in unrealized appreciation on investments		(378,831)	(906,234)	(2,566,523)	(2,566,523)
Net change in unrealized (appreciation) depreciation foreign currency translations		(20,315)	25,757	(11,719)	(11,719)
Increase in investments due to PIK		(313,010)	(1,059,816)	(129,990)
Amortization of premium and accretion of discount, net		(1,021,839)	(678,569)	(502,109)
Deferred tax provision		79,156	91,590	167,865
Amortization of loan structure fees		682,848	306,387	586,127
Amortization of deferred offering costs		224,668	225,050	165,937	165,937
Net realized gain on investments		(1,467,178)		(841,075)	(841,075)
Changes in other assets and liabilities
(Increase) decrease in interest receivable		(397,530)	127,732	(465,307)
Decrease (increase) in other receivable		4,340	(4,340)
Decrease (increase) in related party receivable		2,004	160,451	(152,835)
Decrease (increase) in expense reimbursements receivable from the Advisor		158,893	(34,934)	39,099
Decrease (increase) in prepaid expenses		150,718	(37,331)	5,985
Increase (decrease) in administrative services payable		80,688	(15,931)	58,894
Increase (decrease) in interest payable		251,384	246,728	(196,148)
Increase in income management fees payable		260,005	648,149
Increase in income incentive fees payable		92,434	12,332	111,658
Increase in capital gains incentive fees payable		221,374	44,545	261,684
Increase in unearned revenue		286,077	24,091	357,904
Increase (decrease) in income tax payable		74,921	(131,062)	175,018
(Decrease) increase in other accrued expenses and liabilities		(237,707)	171,164	57,975
Net Cash Used in Operating Activities		(80,605,200)	(73,947,410)	(34,485,537)
Cash Flows from Financing Activities
Proceeds from issuance of common shares of beneficial interest		42,013,679	62,598,161	24,073,114		$ 197,211,378
Offering costs paid for common shares of beneficial interest issued		(157,678)	(280,158)	(184,418)
Purchase of common shares of beneficial interest in tender offer	$ (1,999,989)	(5,200,175)	(7,667,294)
Stockholder distributions paid		(16,513,810)	(20,507,824)	(10,026,553)
Borrowings under Credit Facilities		163,200,000	184,300,000	169,750,000
Repayments of Credit Facilities		(100,000,000)	(141,850,000)	(152,365,000)
Financing costs paid on Credit Facilities		(2,294,037)	(1,095,044)	(387,744)
Short-term loan borrowings				4,500,000
Short-term loan repayments				(15,750,000)
Net Cash Provided by Financing Activities		81,047,979	75,497,841	19,609,399
Net Increase (Decrease) in Cash and Cash Equivalents		442,779	1,550,431	(14,876,138)
Cash and Cash Equivalents Balance at Beginning of Period		2,144,116	593,685	15,469,823
Cash and Cash Equivalents Balance at End of Period	$ 2,144,116	2,586,895	2,144,116	593,685	$ 15,469,823	$ 2,586,895
Supplemental and Non-Cash Activities
Cash paid for interest expense		12,514,693	7,835,549	1,270,834
Income and excise tax paid		23,374	163,245	12,895
Value of common shares of beneficial interest issued pursuant to Dividend Reinvestment Plan		$ 1,329,809	$ 623,113	$ 43,894